GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) saw their shares skyrocket in early 2021 after several Reddit users incited a rally. Investors may have largely lost interest in these two stocks. However, a number of other meme stocks are loved by r/WallStreetBets currently. Maybe they shouldn’t. U.S. equities are in the midst of a rally with the Nasdaq and S&P500
Thanks to the explosive interest in artificial intelligence, the talking point about top software stocks to buy has likewise skyrocketed. Nevertheless, there are other specialties and they offer much relevance to the broader technology narrative. For example, we often hear about the accelerated productivity promises of AI. But what about the nefarious uses? If AI
Today’s article introduces three virtual reality stocks to buy. Once relegated to science fiction, VR is rapidly transforming from a futuristic concept to a tangible reality. Advancements in hardware, such as Apple‘s (NASDAQ:AAPL) Vision Pro and Meta Platform‘s (NASDAQ:META) Meta Quest 3, have greatly improved user experience and accessibility. After decades of anticipation, VR is
Finding the best investment ideas is tricky. The market fluctuates and transitions into different cycles, with the constant temptation to switch your bets to chase trending stocks. However, the most successful investors know that market millionaires aren’t built overnight. Choosing the right stocks to buy and hold presents the most significant potential for growth. And
Not long ago, The Wall Street Journal reported that Nvidia (NASDAQ:NVDA) owned approximately 1.7 million shares of SoundHound AI (NASDAQ:SOUN). Surely, it’s fair to call Nvidia a kingmaker in artificial intelligence. Therefore, investors should conduct their due diligence on SoundHound AI and then consider buying some SOUN stock. Before you hit the “buy” button, though,
Investors’ eyes are closely following the massive rally in pharmaceutical stocks amid the red-hot anti-obesity market. In 2024, the projected revenue for the pharma market is estimated to reach $1.15 trillion. And, oncology drugs are expected to be the largest segment at $214.1 billion, according to Statista. One sub-sector has been of particular interest in